No difference in insulin sensitivity between healthy postmenopausal women with or without sarcopenia: a pilot study

Area of Science:

• Gerontology
• Metabolism
• Muscle Physiology

Background:

• Insulin is crucial for muscle protein metabolism, but its effectiveness declines with age.
• Sarcopenia, the age-related loss of muscle mass, is a growing concern.
• The link between age-related insulin resistance and sarcopenia is suspected but not well-established.

Purpose of the Study:

• To compare insulin sensitivity (IS) in postmenopausal women with and without sarcopenia.
• To investigate the role of IS in the development and maintenance of sarcopenia.

Main Methods:

• Compared IS using the quantitative insulin sensitivity check index (QUICKI) in 44 postmenopausal women (20 class I sarcopenics, 8 class II sarcopenics, 16 non-sarcopenics).
• Assessed muscle mass index (MMI), fat-free mass (FFM), fat mass (FM), and trunk FM using dual-energy X-ray absorptiometry.
• Measured energy expenditure (resting, daily, physical activity) via accelerometry and indirect calorimetry.
• Collected dietary data (total energy, protein, carbohydrate intake) through 3-day food records.

Main Results:

• Significant differences in MMI and FFM were observed among the groups.
• No significant differences were found in IS (QUICKI), FM, TFM, energy expenditure, or dietary intake across the groups.
• This indicates that sarcopenia in this cohort was not associated with altered insulin sensitivity.

Conclusions:

• Insulin action, as measured by QUICKI, does not appear to be a significant factor in the development or maintenance of sarcopenia in healthy, non-obese, postmenopausal women.
• The findings suggest that other mechanisms may be more critical in the etiology of sarcopenia in this population.